{"id":8174,"date":"2025-04-04T03:30:11","date_gmt":"2025-04-03T19:30:11","guid":{"rendered":"https:\/\/regask.com\/?p=8174"},"modified":"2025-04-09T14:29:54","modified_gmt":"2025-04-09T06:29:54","slug":"%e3%83%a1%e3%82%ad%e3%82%b7%e3%82%b3gmp%e3%82%b3%e3%83%b3%e3%83%97%e3%83%a9%e3%82%a4%e3%82%a2%e3%83%b3%e3%82%b92025","status":"publish","type":"post","link":"https:\/\/regask.com\/ja\/mexico-gmp-compliance-2025\/","title":{"rendered":"COFEPRIS\uff08\u30e1\u30ad\u30b7\u30b3\uff09\u304cGMP\u6587\u66f8\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u516c\u958b\u2026"},"content":{"rendered":"<p data-pm-slice=\"1 3 []\">2025\u5e743\u670820\u65e5\u3001\u30e1\u30ad\u30b7\u30b3\u9023\u90a6\u5065\u5eb7\u30ea\u30b9\u30af\u4fdd\u8b77\u59d4\u54e1\u4f1a\uff08COFEPRIS\uff09\u306f\u3001\u5b98\u5831\uff08DOF\uff09\u306b\u304a\u3044\u3066\u3001\u300c\u6709\u52b9\u6210\u5206\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u306e\u9069\u6b63\u88fd\u9020\u57fa\u6e96\uff08GMP\uff09\u3092\u4fdd\u8a3c\u3059\u308b\u6587\u66f8\u63d0\u51fa\u306b\u95a2\u3059\u308b\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u767a\u884c\u306b\u95a2\u3059\u308b\u5354\u5b9a\u300d\u3092\u516c\u5e03\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306f\u3001\u65b0\u898f\u5065\u5eb7\u767b\u9332\u306e\u7533\u8acb\u3001\u306a\u3089\u3073\u306b\u305d\u306e\u5ef6\u9577\u304a\u3088\u3073\u5909\u66f4\u306b\u9069\u7528\u3055\u308c\u307e\u3059\u3002\u65b0\u305f\u306b\u5236\u5b9a\u3055\u308c\u305f\u898f\u5247\u306f\u3001GMP\u6587\u66f8\u306e\u63d0\u51fa\u306b\u95a2\u3059\u308b\u8981\u4ef6\u3068\u57fa\u6e96\u3092\u5b9a\u7fa9\u3057\u3001\u56fd\u969b\u57fa\u6e96\u3078\u306e\u6e96\u62e0\u3092\u5408\u7406\u5316\u3057\u3001\u8a8d\u5b9a\u898f\u5236\u5f53\u5c40\u3068\u306e\u5354\u529b\u3092\u5f37\u5316\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<h4><strong>\u4e3b\u306a\u30cf\u30a4\u30e9\u30a4\u30c8<\/strong><\/h4>\n<ul data-spread=\"false\">\n<li>\u3053\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u306f\u3001\u533b\u85ac\u54c1\u539f\u6599\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u306e\u5065\u5eb7\u767b\u9332\u7533\u8acb\u3001\u66f4\u65b0\u3001\u5909\u66f4\u306b\u5fc5\u8981\u306a\u9069\u6b63\u88fd\u9020\u57fa\u6e96\u8a3c\u660e\u66f8\u3084\u540c\u7b49\u306e\u6587\u66f8\u306a\u3069\u306e\u5fc5\u8981\u306a\u6587\u66f8\u304c\u6307\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/li>\n<li>\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u3092\u901a\u3058\u3066\u88fd\u54c1\u306e\u5b89\u5168\u6027\u3001\u6709\u52b9\u6027\u3001\u4e00\u8cab\u6027\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306b\u3001\u56fd\u969b GMP \u57fa\u6e96\u3078\u306e\u6e96\u62e0\u306b\u91cd\u70b9\u304c\u7f6e\u304b\u308c\u3066\u3044\u307e\u3059\u3002<\/li>\n<li>\u5f71\u97ff\u3092\u53d7\u3051\u308b\u88fd\u54c1\u30ab\u30c6\u30b4\u30ea\u306f\u6b21\u306e\u3068\u304a\u308a\u3067\u3059\u3002\n<ul data-spread=\"false\">\n<li>\u533b\u85ac\u54c1\u6709\u52b9\u6210\u5206\uff08API\uff09<\/li>\n<li>\u5e02\u8ca9\u85ac\uff08OTC\uff09<\/li>\n<li>\u51e6\u65b9\u85ac<\/li>\n<li>\u8a3a\u65ad\u6a5f\u5668\u3084\u6cbb\u7642\u6a5f\u5668\u3092\u542b\u3080\u3055\u307e\u3056\u307e\u306a\u533b\u7642\u6a5f\u5668<\/li>\n<\/ul>\n<\/li>\n<li>\u3053\u306e\u898f\u5236\u306f\u3001\u4e16\u754c\u7684\u306b\u8a8d\u3081\u3089\u308c\u305f\u898f\u5236\u5f53\u5c40\u3068\u306e\u9023\u643a\u3092\u4fc3\u9032\u3057\u3001\u6e96\u62e0\u3057\u305f\u88fd\u54c1\u304c\u56fd\u969b\u5e02\u5834\u3067\u3088\u308a\u5bb9\u6613\u306b\u5165\u624b\u3067\u304d\u308b\u3088\u3046\u306b\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li>\u88fd\u9020\u696d\u8005\u306f\u3001\u767b\u9332\u30b9\u30c6\u30fc\u30bf\u30b9\u3092\u7dad\u6301\u3057\u3001\u65b0\u898f\u307e\u305f\u306f\u4fee\u6b63\u3055\u308c\u305f\u5065\u5eb7\u767b\u9332\u306e\u627f\u8a8d\u30d7\u30ed\u30bb\u30b9\u3092\u3088\u308a\u30b9\u30e0\u30fc\u30ba\u306b\u3059\u308b\u305f\u3081\u306b\u3001\u3053\u308c\u3089\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u53b3\u5b88\u3059\u308b\u3053\u3068\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002<\/li>\n<\/ul>\n<h4><strong>\u6b21\u306e\u30b9\u30c6\u30c3\u30d7<\/strong><\/h4>\n<ul data-spread=\"false\">\n<li>\u88fd\u9020\u696d\u8005\u306f\u3001\u65b0\u3057\u3044 COFEPRIS \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u6e96\u62e0\u3059\u308b\u3088\u3046\u306b GMP \u6587\u66f8\u3092\u8a55\u4fa1\u304a\u3088\u3073\u66f4\u65b0\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li>\u4f01\u696d\u306f\u3001\u81ea\u793e\u306e\u751f\u7523\u30d7\u30ed\u30bb\u30b9\u3068\u54c1\u8cea\u7ba1\u7406\u30b7\u30b9\u30c6\u30e0\u304c\u6539\u8a02\u3055\u308c\u305f\u898f\u5236\u306e\u8981\u6c42\u3092\u6e80\u305f\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u78ba\u8a8d\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li>\u898f\u5236\u306e\u66f4\u65b0\u3092\u7dbf\u5bc6\u306b\u76e3\u8996\u3057\u3001COFEPRIS \u3068\u7a4d\u6975\u7684\u306b\u9023\u643a\u3059\u308b\u3053\u3068\u304c\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u7dad\u6301\u3057\u3001\u627f\u8a8d\u30d7\u30ed\u30bb\u30b9\u3092\u5408\u7406\u5316\u3059\u308b\u305f\u3081\u306b\u4e0d\u53ef\u6b20\u3067\u3059\u3002<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>2025\u5e743\u670820\u65e5\u3001\u30e1\u30ad\u30b7\u30b3\u9023\u90a6\u4fdd\u5065\u30ea\u30b9\u30af\u4fdd\u8b77\u59d4\u54e1\u4f1a\uff08COFEPRIS\uff09\u306f\u3001\u5b98\u5831\uff08DOF\uff09\u306b\u3001\u6709\u52b9\u6210\u5206\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u306e\u9069\u6b63\u88fd\u9020\u898f\u7bc4\uff08GMP\uff09\u3092\u4fdd\u8a3c\u3059\u308b\u6587\u66f8\u306e\u63d0\u51fa\u306b\u95a2\u3059\u308b\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u767a\u884c\u3059\u308b\u5354\u5b9a\u3092\u63b2\u8f09\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306f\u3001\u65b0\u898f\u4fdd\u5065\u767b\u9332\u7533\u8acb\u3001\u304a\u3088\u3073\u305d\u306e\u5ef6\u9577\u3068\u5909\u66f4\u306b\u9069\u7528\u3055\u308c\u307e\u3059\u3002\u65b0\u305f\u306b\u5236\u5b9a\u3055\u308c\u305f\u898f\u5236\u306f\u3001GMP\u6587\u66f8\u306e\u63d0\u51fa\u8981\u4ef6\u3068\u57fa\u6e96\u3092\u5b9a\u7fa9\u3057\u3001\u56fd\u969b\u57fa\u6e96\u3078\u306e\u6e96\u62e0\u3092\u5408\u7406\u5316\u3057\u3001\u8a8d\u3081\u3089\u308c\u305f\u898f\u5236\u5f53\u5c40\u3068\u306e\u5354\u529b\u3092\u5f37\u5316\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u4e3b\u306a\u8981\u70b9 \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u306f\u3001\u533b\u85ac\u54c1\u6210\u5206\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u306b\u5fc5\u8981\u306a\u9069\u6b63\u88fd\u9020\u898f\u7bc4\u8a3c\u660e\u66f8\u307e\u305f\u306f\u540c\u7b49\u306e\u6587\u66f8\u3092\u542b\u3080\u3001\u5fc5\u8981\u306a\u6587\u66f8\u3092\u898f\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>","protected":false},"author":43,"featured_media":8207,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[521,35],"tags":[609],"class_list":["post-8174","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mexico-regulations","category-pharma-biotech-latest-insights","tag-guideline"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Mexico GMP 2025: Key Updates | RegASK<\/title>\n<meta name=\"description\" content=\"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, &amp; devices.Ensure seamless compliance now.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/ja\/\u30e1\u30ad\u30b7\u30b3gmp\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b92025\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COFEPRIS (Mexico) Publishes Guidelines for GMP Documentation for Active Ingredients, Medicines, and Medical Devices Submissions\" \/>\n<meta property=\"og:description\" content=\"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, &amp; devices.Ensure seamless compliance now.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/ja\/\u30e1\u30ad\u30b7\u30b3gmp\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b92025\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T19:30:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-09T06:29:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"COFEPRIS (Mexico) Publishes Guidelines for GMP Document&hellip;\",\"datePublished\":\"2025-04-03T19:30:11+00:00\",\"dateModified\":\"2025-04-09T06:29:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"keywords\":[\"Guideline\"],\"articleSection\":[\"Mexico\",\"Pharma and Biotech\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\",\"name\":\"Mexico GMP 2025: Key Updates | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"datePublished\":\"2025-04-03T19:30:11+00:00\",\"dateModified\":\"2025-04-09T06:29:54+00:00\",\"description\":\"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, & devices.Ensure seamless compliance now.\",\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"width\":800,\"height\":600,\"caption\":\"Cofepris Mexico Publishes Guidelines Gmp Documentation Active Ingredients Medicines Medical Devices Submissions\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u30e1\u30ad\u30b7\u30b3GMP 2025\uff1a\u4e3b\u306a\u6700\u65b0\u60c5\u5831 | RegASK","description":"\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u78ba\u4fdd\u3057\u307e\u3057\u3087\u3046\uff01COFEPRIS\u306f2025\u5e74\u306bGMP\u898f\u5247\u3092\u66f4\u65b0\u3057\u307e\u3059\u3002API\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u5909\u66f4\u70b9\u3002\u4eca\u3059\u3050\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u78ba\u4fdd\u3057\u307e\u3057\u3087\u3046\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/ja\/\u30e1\u30ad\u30b7\u30b3gmp\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b92025\/","og_locale":"ja_JP","og_type":"article","og_title":"COFEPRIS (Mexico) Publishes Guidelines for GMP Documentation for Active Ingredients, Medicines, and Medical Devices Submissions","og_description":"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, & devices.Ensure seamless compliance now.","og_url":"https:\/\/regask.com\/ja\/\u30e1\u30ad\u30b7\u30b3gmp\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b92025\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-04-03T19:30:11+00:00","article_modified_time":"2025-04-09T06:29:54+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u57f7\u7b46\u8005":"Reva Ananda","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#article","isPartOf":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"COFEPRIS (Mexico) Publishes Guidelines for GMP Document&hellip;","datePublished":"2025-04-03T19:30:11+00:00","dateModified":"2025-04-09T06:29:54+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/"},"wordCount":269,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","keywords":["Guideline"],"articleSection":["Mexico","Pharma and Biotech"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/","url":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/","name":"\u30e1\u30ad\u30b7\u30b3GMP 2025\uff1a\u4e3b\u306a\u6700\u65b0\u60c5\u5831 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","datePublished":"2025-04-03T19:30:11+00:00","dateModified":"2025-04-09T06:29:54+00:00","description":"\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u78ba\u4fdd\u3057\u307e\u3057\u3087\u3046\uff01COFEPRIS\u306f2025\u5e74\u306bGMP\u898f\u5247\u3092\u66f4\u65b0\u3057\u307e\u3059\u3002API\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u306b\u95a2\u3059\u308b\u91cd\u8981\u306a\u5909\u66f4\u70b9\u3002\u4eca\u3059\u3050\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3092\u78ba\u4fdd\u3057\u307e\u3057\u3087\u3046\u3002","inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/mexico-gmp-compliance-2025\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","width":800,"height":600,"caption":"Cofepris Mexico Publishes Guidelines Gmp Documentation Active Ingredients Medicines Medical Devices Submissions"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u9ad8\u6027\u80fd\u30c1\u30fc\u30e0\u306e\u305f\u3081\u306e\u898f\u5236AI\u30aa\u30da\u30ec\u30fc\u30c6\u30a3\u30f3\u30b0\u30b7\u30b9\u30c6\u30e0","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"\u30ec\u30f4\u30a1\u30fb\u30a2\u30ca\u30f3\u30c0"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/8174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/comments?post=8174"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/8174\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media\/8207"}],"wp:attachment":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media?parent=8174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/categories?post=8174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/tags?post=8174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}